Insights

Vaccine Development Focus Hawaii Biotech specializes in developing vaccines for emerging and established infectious diseases such as West Nile, Zika, and COVID-19, indicating strong opportunities for partnering on new vaccine projects or expanding distribution channels for their existing candidates.

Biodefense Expertise The company's development of biodefense drugs and antitoxins for anthrax and bacterial toxins positions it as a key player in government and defense contracts, suggesting potential for collaborations with agencies seeking advanced biodefense solutions.

Funding & Growth Potential With recent federal funding and a revenue range of 10 to 25 million dollars, Hawaii Biotech presents opportunities for investment, partnerships, or supply agreements to accelerate their clinical trials and expand product offerings.

Recent Leadership Changes The retirement of CEO Elliot Parks in 2021 may open avenues for new leadership collaborations and strategic discussions to leverage the company's R&D expertise amid leadership transition.

Technology & Innovation Hawaii Biotech's proprietary vaccine adjuvants and recombinant protein technology create opportunities for partners interested in innovative vaccine formulation, specializing in next-generation immunization strategies specific to infectious diseases and biodefense.

Hawaii Biotech, Inc. Tech Stack

Hawaii Biotech, Inc. uses 8 technology products and services including WordPress, Open Graph, Cloudflare, and more. Explore Hawaii Biotech, Inc.'s tech stack below.

  • WordPress
    Content Management System
  • Open Graph
    Content Management System
  • Cloudflare
    Content Management System
  • Microsoft 365
    Email
  • jQuery Migrate
    Javascript Libraries
  • Underscore.js
    Javascript Libraries
  • PHP
    Programming Languages
  • Bootstrap
    UI Frameworks

Media & News

Hawaii Biotech, Inc.'s Email Address Formats

Hawaii Biotech, Inc. uses at least 1 format(s):
Hawaii Biotech, Inc. Email FormatsExamplePercentage
FLast@hibiotech.comJDoe@hibiotech.com
57%
Last@hibiotech.comDoe@hibiotech.com
36%
F.Last@hibiotech.comJ.Doe@hibiotech.com
5%
First.Last@hibiotech.comJohn.Doe@hibiotech.com
2%

Frequently Asked Questions

Where is Hawaii Biotech, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Hawaii Biotech, Inc.'s main headquarters is located at 650 Iwilei Road, Suite 204 Honolulu, Hawaii 96817, US. The company has employees across 1 continents, including North America.

What is Hawaii Biotech, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Hawaii Biotech, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Hawaii Biotech, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Hawaii Biotech, Inc.'s official website is hibiotech.com and has social profiles on LinkedInCrunchbase.

How much revenue does Hawaii Biotech, Inc. generate?

Minus sign iconPlus sign icon
As of October 2025, Hawaii Biotech, Inc.'s annual revenue is estimated to be $8.2M.

What is Hawaii Biotech, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Hawaii Biotech, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Hawaii Biotech, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2025, Hawaii Biotech, Inc. has approximately 15 employees across 1 continents, including North America. Key team members include Coo/Cfo: L. K.Founder And Scientific Consultant: T. H.Director - Vaccine Research: D. C.. Explore Hawaii Biotech, Inc.'s employee directory with LeadIQ.

What industry does Hawaii Biotech, Inc. belong to?

Minus sign iconPlus sign icon
Hawaii Biotech, Inc. operates in the Biotechnology Research industry.

What technology does Hawaii Biotech, Inc. use?

Minus sign iconPlus sign icon
Hawaii Biotech, Inc.'s tech stack includes WordPressOpen GraphCloudflareMicrosoft 365jQuery MigrateUnderscore.jsPHPBootstrap.

What is Hawaii Biotech, Inc.'s email format?

Minus sign iconPlus sign icon
Hawaii Biotech, Inc.'s email format typically follows the pattern of FLast@hibiotech.com. Find more Hawaii Biotech, Inc. email formats with LeadIQ.

How much funding has Hawaii Biotech, Inc. raised to date?

Minus sign iconPlus sign icon
As of October 2025, Hawaii Biotech, Inc. has raised $7.4M in funding. The last funding round occurred on Feb 05, 2014 for $7.4M.

When was Hawaii Biotech, Inc. founded?

Minus sign iconPlus sign icon
Hawaii Biotech, Inc. was founded in 1982.

Hawaii Biotech, Inc.

Biotechnology ResearchUnited States11-50 Employees

Hawaii Biotech, Inc. (HBI) is a privately held biotechnology company focused on the research and development of vaccines for established and emerging infectious diseases. The company has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. Current vaccine candidates in clinical or pre-clinical development target the West Nile virus, Tick borne flaviviruses, Zika virus, Crimean-Congo hemorrhagic fever virus, and Chikungunya virus. HBI’s drug development activities are focused on small molecule drugs that block intracellular and extracellural bacterial toxins. Product opportunities include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company also partners its proprietary saponin adjuvant for vaccine development.

Section iconCompany Overview

Headquarters
650 Iwilei Road, Suite 204 Honolulu, Hawaii 96817, US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1982
Employees
11-50

Section iconFunding & Financials

  • $7.4M

    Hawaii Biotech, Inc. has raised a total of $7.4M of funding over 4 rounds. Their latest funding round was raised on Feb 05, 2014 in the amount of $7.4M.

  • $10M$25M

    Hawaii Biotech, Inc.'s revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $7.4M

    Hawaii Biotech, Inc. has raised a total of $7.4M of funding over 4 rounds. Their latest funding round was raised on Feb 05, 2014 in the amount of $7.4M.

  • $10M$25M

    Hawaii Biotech, Inc.'s revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.